104 related articles for article (PubMed ID: 26615920)
1. In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.
Adeola HA; Calder B; Soares NC; Kaestner L; Blackburn JM; Zerbini LF
Future Oncol; 2016 Jan; 12(1):43-57. PubMed ID: 26615920
[TBL] [Abstract][Full Text] [Related]
2. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
3. [Update on the diagnosis of PCa in urine. The current role of urine markers].
Fernandez-Serra A; Casanova-Salas I; Rubio L; Calatrava A; García-Flores M; García-Casado Z; López-Guerrero JA; Rubio-Briones J
Arch Esp Urol; 2015 Apr; 68(3):240-9. PubMed ID: 25948797
[TBL] [Abstract][Full Text] [Related]
4. Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis.
Nurdin A; Hoshi Y; Yoneyama T; Miyauchi E; Tachikawa M; Watanabe M; Terasaki T
J Pharm Sci; 2016 Nov; 105(11):3440-3452. PubMed ID: 27665127
[TBL] [Abstract][Full Text] [Related]
5. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
6. Identification of prostate cancer biomarkers in urinary exosomes.
Øverbye A; Skotland T; Koehler CJ; Thiede B; Seierstad T; Berge V; Sandvig K; Llorente A
Oncotarget; 2015 Oct; 6(30):30357-76. PubMed ID: 26196085
[TBL] [Abstract][Full Text] [Related]
7. Precise quantitation of 136 urinary proteins by LC/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and/or verification studies.
Percy AJ; Yang J; Hardie DB; Chambers AG; Tamura-Wells J; Borchers CH
Methods; 2015 Jun; 81():24-33. PubMed ID: 25858257
[TBL] [Abstract][Full Text] [Related]
8. DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery.
Zhu T; Zhu Y; Xuan Y; Gao H; Cai X; Piersma SR; Pham TV; Schelfhorst T; Haas RRGD; Bijnsdorp IV; Sun R; Yue L; Ruan G; Zhang Q; Hu M; Zhou Y; Van Houdt WJ; Le Large TYS; Cloos J; Wojtuszkiewicz A; Koppers-Lalic D; Böttger F; Scheepbouwer C; Brakenhoff RH; van Leenders GJLH; Ijzermans JNM; Martens JWM; Steenbergen RDM; Grieken NC; Selvarajan S; Mantoo S; Lee SS; Yeow SJY; Alkaff SMF; Xiang N; Sun Y; Yi X; Dai S; Liu W; Lu T; Wu Z; Liang X; Wang M; Shao Y; Zheng X; Xu K; Yang Q; Meng Y; Lu C; Zhu J; Zheng J; Wang B; Lou S; Dai Y; Xu C; Yu C; Ying H; Lim TK; Wu J; Gao X; Luan Z; Teng X; Wu P; Huang S; Tao Z; Iyer NG; Zhou S; Shao W; Lam H; Ma D; Ji J; Kon OL; Zheng S; Aebersold R; Jimenez CR; Guo T
Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):104-119. PubMed ID: 32795611
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways.
Lima T; Henrique R; Vitorino R; Fardilha M
Med Oncol; 2021 Jan; 38(1):9. PubMed ID: 33452612
[TBL] [Abstract][Full Text] [Related]
10. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry.
Adeola HA; Soares NC; Paccez JD; Kaestner L; Blackburn JM; Zerbini LF
Proteomics Clin Appl; 2015 Jun; 9(5-6):597-609. PubMed ID: 25708745
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for prostate cancer.
Schiffer E
World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer proteomics.
Masters JR
OMICS; 2011 Mar; 15(3):169-71. PubMed ID: 21319990
[TBL] [Abstract][Full Text] [Related]
14. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
Mermelekas G; Vlahou A; Zoidakis J
Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine.
Sandow JJ; Rainczuk A; Infusini G; Makanji M; Bilandzic M; Wilson AL; Fairweather N; Stanton PG; Garama D; Gough D; Jobling TW; Webb AI; Stephens AN
Proteomics Clin Appl; 2018 May; 12(3):e1700135. PubMed ID: 29426060
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
Chen YT; Chen HW; Domanski D; Smith DS; Liang KH; Wu CC; Chen CL; Chung T; Chen MC; Chang YS; Parker CE; Borchers CH; Yu JS
J Proteomics; 2012 Jun; 75(12):3529-45. PubMed ID: 22236518
[TBL] [Abstract][Full Text] [Related]
17. Prioritization of candidate protein biomarkers from an in vitro model system of breast tumor progression toward clinical verification.
Lau TY; Power KA; Dijon S; de Gardelle I; McDonnell S; Duffy MJ; Pennington SR; Gallagher WM
J Proteome Res; 2010 Mar; 9(3):1450-9. PubMed ID: 20000743
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers.
Ma W; Diep K; Fritsche HA; Shore N; Albitar M
Genet Test Mol Biomarkers; 2014 Mar; 18(3):156-63. PubMed ID: 24512523
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis.
Lin JF; Xu J; Tian HY; Gao X; Chen QX; Gu Q; Xu GJ; Song JD; Zhao FK
Int J Cancer; 2007 Dec; 121(12):2596-605. PubMed ID: 17722004
[TBL] [Abstract][Full Text] [Related]
20. Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.
Kim Y; Jeon J; Mejia S; Yao CQ; Ignatchenko V; Nyalwidhe JO; Gramolini AO; Lance RS; Troyer DA; Drake RR; Boutros PC; Semmes OJ; Kislinger T
Nat Commun; 2016 Jun; 7():11906. PubMed ID: 27350604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
